Navigation Links
WHO data confirms low level of resistance to Tamiflu

p>

2004/2005 618 0 252 1(0.4%)

2005/2006 429 4 (0.9%) 163 0

Total 2227 7 (0.32%) 586 1 (0.17%)

These preliminary findings indicate that a low frequency of oseltamivir resistance was present in community isolates during influenza seasons in which there had been substantial oseltamivir use in Japan. Low frequencies of oseltamivir resistance in influenza A viruses (<0.5%) were also detected in isolates collected through the WHO Global Influenza Surveillance Network during the first 3 years (1999?002) after the introduction of the neuraminidase inhibitors into clinical use.

Resistance to H5N1 avian virus

The possible development of anti-viral resistance is of concern for pandemic planning and preparedness. However, to date, there have only been three documented cases of Tamiflu resistance to avian influenza H5N1. 3,4 In one case, the prophylactic dose (75 mg daily) rather than the treatment dose (75 mg twice daily) was given to a patient already exhibiting clinical symptoms, thus under-dosing the patient and increasing the risk of resistance.3 Once the twice daily treatment dose was provided, the patient recovered from her illness. Again this resistant virus was shown to cause less severe infection and was less capable of transmission. In the other two cases, the recommended dose and duration of oseltamivir was followed.4 However, while one patient received treatment on the second day of illness, the other patient started treatment late, on the sixth day of illness. Two further possible cases of resistance of H5N1 to Tamiflu in Egypt have been identified and are currently under investigation.

Roche’s efforts to support government pandemic stockpiling

Recently, the World Health Organization (WHO) reconfirmed the need for world governments to be vigilant in their plans to protect against a potential pandemic outbreak. WHO also reconfirmed that stockpiling antivirals - in particular o
'"/>

Source:Ketchum


Page: 1 2 3

Related biology news :

1. LUCA technologies confirms real-time methane generation
2. Ancient DNA confirms single origin of Malagasy primates
3. Updated data on novel HPV vaccine confirms efficacy in large population
4. First human study confirms that immune cells can be a primary cause of bone loss in gum disease
5. New method confirms importance of fungi in Arctic nitrogen cycle
6. New data from NIH lab confirms protocol to reverse type 1 diabetes in mice
7. Genetic surprise confirms neglected 70-year-old evolutionary hypothesis
8. Re-analysis of cigarettes confirms tobacco companies increased addictive nicotine 11 percent
9. Cornell lab confirms deadly fish virus spreading to new species
10. Unprecedented water level rise in Somalia
11. Low level of extinction during ice age linked to adaptability
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: WHO data confirms low level resistance Tamiflu

(Date:2/5/2015)... 28, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... Global Online CEO Conference on January 29 th ... Pereira , CEO of NXT-ID will present and host ... Wocket smart wallet and its full suite of biometric ...
(Date:2/5/2015)... Calif. , Jan. 30, 2015  It is ... great power and potential for genomic science as a ... in disease prevention and treatment.  I was honored to ... new, government-funded precision medicine program. Since ... the science of genomics—from the first sequenced genome of ...
(Date:1/22/2015)... Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the addition ... report to their offering. , The primary ... is who she/he is claiming to be, and for this ... physical characteristics, such as fingerprint, hand or palm print, iris, ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
... of Virginia have discovered a switching mechanism in the ... sleep/wake cycles in mammals. The new finding demonstrates ... to setting the rhythms of the brain,s primary timekeeper, ... "The finding is significant because it changes our ...
... of bioengineering at Clemson University and the CU-MUSC ... Career Translational Research Award from the Wallace H. ... on an injectable hydrogel-based system for the treatment ... that can progress towards commercial development and clinical ...
... (OTC Bulletin,Board: CICI) Communication Intelligence Corporation ("CIC" ... solutions for,business process automation in the financial industry ... today its financial,results for the three and six-month ... for the three months ended June 30, 2008 ...
Cached Biology News:Light receptors in eye play key role in setting biological clock, study shows 2Clemson bioengineer wins prestigious Early Career Award 2Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results 2Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results 3Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results 4Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results 5Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results 6
(Date:2/27/2015)... Scotia (PRWEB) February 27, 2015 ... vaccine and immunotherapy company, today announced that the ... application for Fast Track designation and Phase I ... in conjunction with the mutual co-development agreement signed ... obtained Fast Track designation for the DPX-Survivac. , ...
(Date:2/27/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY) is to present important ... patients with metastatic renal cancer at the ASCO Genitourinary ... The data will be presented by Dr. Sumanta ... Center in California in his ... Ferritin and IL-8 as two baseline biomarkers that correlate ...
(Date:2/27/2015)... Illinois (PRWEB) February 27, 2015 FamilyFarms ... Sims, General Manager of State Line Farms, received the ... recognizes a producer, under the age of 35, who ... "It is an honor to win the Tomorrow's Top ... discovering who won the Top Producer Award and learning ...
(Date:2/27/2015)... 2015  Steep Hill, the industry leader in cannabis ... to open a full service medical cannabis quality assurance ... bringing advanced scientific tools and methodology to the state, ... is currently the only laboratory licensed by the New ... testing in order to meet the recently adopted regulatory ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2
... ... premixed formulation, DEERFIELD, Ill., ... U.S. Food and Drug Administration (FDA) has approved a,new premixed ... Discovered and developed by Astellas,Vaprisol, an arginine vasopressin (AVP) receptor ...
... Halozyme Therapeutics,Inc. (Nasdaq: HALO ), a biopharmaceutical company ... it will present at three upcoming investor conferences:, ... Hyatt Regency in La,Jolla, Calif. on Monday, October 27, ... -- Oppenheimer,s 19th Annual Healthcare Conference to be held ...
... Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced today that the ... on October 28, 2008 at 2:00 p.m.,Pacific Time (5:00 ... La,Jolla, California. Jack Lief, Arena,s President and Chief Executive,Officer, ... including its,clinical development and discovery programs., A live ...
Cached Biology Technology:FDA Approves Astellas' Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia 2FDA Approves Astellas' Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia 3FDA Approves Astellas' Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia 4Halozyme Therapeutics to Present at Upcoming Investor Conferences 2Arena Pharmaceuticals to Present at the BIOCOM Investor Conference 2Arena Pharmaceuticals to Present at the BIOCOM Investor Conference 3
Anti-HumanLactoferrin...
Rabbit monoclonal [EP881Y] to EEF2K ( Abpromise for all tested applications). Antigen: Synthetic peptide corresponding to residues in the C-terminal of human EEF2K. Entrez GeneID: 29904 S...
ICAD Purified Anti-Mouse clone Polyclonal, Isotype Rabbit Ig, 200 µl Consult technical datasheet for details....
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications)....
Biology Products: